文献速递腹部MR

局灶性自身免疫性胰腺炎与胰腺导管腺癌的鉴别:以动脉期为重点的对比增强MRI

Differentiating focal autoimmune pancreatitis and pancreatic ductal adenocarcinoma: contrast-enhanced MRI with special emphasis on the arterial phase.
PubMed 文献 · Eur Radiol · 2019-04-26

纳入36例局灶性自身免疫性胰腺炎(AIP)与72例胰腺导管腺癌(PDA)患者,比较三相对比增强MRI各期病灶对比度(SI胰腺/SI病灶)。动脉期病灶对比度在两组间差异最大,以≤1.41诊断AIP的敏感度94.4%、特异度87.5%,以>1.41诊断PDA的敏感度87.5%、特异度94.4%。定量分析动脉期病灶对比度有助于鉴别两种病变,其诊断效能与关键影像特征相当或更高。

要点

  • 动脉期病灶对比度(SI胰腺/SI病灶)≤1.41诊断局灶性AIP:敏感度94.4%、特异度87.5%。
  • 动脉期病灶对比度>1.41诊断PDA:敏感度87.5%、特异度94.4%。
  • 除晕征和离散肿块外,动脉期病灶对比度的诊断效能与各关键影像特征相当或更高。

核心结论

  • 对比增强MRI定量分析病灶对比度,尤其是动脉期,有助于鉴别局灶性AIP与PDA;动脉期病灶对比度的诊断效能与关键影像特征大多相当或更高。

研究设计与样本

  • 纳入36例局灶性AIP与72例PDA患者,均行三相对比增强MRI,测量各期肿块与正常胰腺信号强度并计算病灶对比度(SI胰腺/SI肿块),比较两组差异并以最佳截断值评估诊断效能。

关键影像表现/征象

  • 局灶性AIP与PDA的病灶对比度在所有增强期均存在显著差异,以动脉期差异最大。
  • 原文提及的关键影像特征包括晕征和离散肿块,但未给出各特征的具体定义或描述。

诊断标准与关键数值

  • 动脉期病灶对比度≤1.41诊断局灶性AIP:敏感度94.4%、特异度87.5%。
  • 动脉期病灶对比度>1.41诊断PDA:敏感度87.5%、特异度94.4%。
  • 局灶性AIP各关键影像特征敏感度38.9%-88.9%、特异度48.6%-95.8%;PDA各关键影像特征敏感度40.3%-68.1%、特异度72.2%-94.4%。

临床应用与阅片要点

  • 可在对比增强MRI动脉期测量病灶与正常胰腺信号强度并计算SI胰腺/SI病灶,辅助鉴别局灶性AIP与PDA。
  • 动脉期病灶对比度与晕征、离散肿块等关键影像特征的诊断效能相当或更高,但原文未据此给出具体推荐意见。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To compare focal-type autoimmune pancreatitis (AIP) and pancreatic ductal adenocarcinoma (PDA) using contrast-enhanced MR imaging (CE-MRI), and to assess diagnostic performance of the lesion contrast at arterial phase (AP) (ContrastAP) for differentiating between the two diseases.

METHODS: Thirty-six patients with focal-type AIP and 72 patients with PDA were included. All included patients underwent CE-MRI with triple phases. The signal intensity (SI) of the mass and normal pancreas was measured at each phase, and the lesion contrast (SIpancreas/SImass) was compared between AIP and PDA groups. The sensitivity and specificity of ContrastAP using an optimal cutoff point were compared with those of key imaging features specific to AIP and PDA.

RESULTS: The lesion contrast differed significantly between AIP and PDA groups at all phases of CE-MRI; the maximum difference was observed at AP. For AIP, the sensitivity (94.4%) and specificity (87.5%) of ContrastAP (cutoff ≤ 1.41) were comparable or significantly higher than those of all key imaging features (sensitivity, 38.9-88.9%; specificity, 48.6-95.8%), except for the halo sign. For PDA, the sensitivity (87.5%) and specificity (94.4%) of ContrastAP (cutoff > 1.41) were comparable or significantly higher than those of all key imaging features (sensitivity, 40.3-68.1%; specificity, 72.2-94.4%), except for the discrete mass.

CONCLUSIONS: Quantitative analysis of the lesion contrast using CE-MRI, particularly at AP, was helpful to differentiate focal-type AIP from PDA. The diagnostic performance of ContrastAP was mostly comparable or higher than those of the key imaging features.

KEY POINTS: • Diagnosis of focal-type AIP vs. PDA using imaging techniques is extremely challenging. • Lesion contrast in the arterial-phase MRI differs significantly between focal-type AIP and PDA. • Quantitative analysis of lesion contrast using CE-MRI, particularly at the arterial phase, is helpful to differentiate focal-type AIP from PDA.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Kwon JH, Kim JH, Kim SY, et al. Differentiating focal autoimmune pancreatitis and pancreatic ductal adenocarcinoma: contrast-enhanced MRI with special emphasis on the arterial phase. Eur Radiol. 2019. PMID: 31028441. doi:10.1007/s00330-019-06200-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。